Cargando…

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy

AIMS: The aim of this study was to determine whether growth differentiation factor-15 (GDF-15) predicts mortality and morbidity after cardiac resynchronization therapy (CRT). Growth differentiation factor-15, a transforming growth factor-β-related cytokine which is up-regulated in cardiomyocytes via...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foley, Paul W.X., Stegemann, Berthold, Ng, Kelvin, Ramachandran, Sud, Proudler, Anthony, Frenneaux, Michael P., Ng, Leong L., Leyva, Francisco
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777028/ https://www.ncbi.nlm.nih.gov/pubmed/19666898 http://dx.doi.org/10.1093/eurheartj/ehp300

Ejemplares similares

What is treatment success in cardiac resynchronization therapy?
por: Foley, Paul W.X., et al.
Publicado: (2009)

Radial dyssynchrony assessed by cardiovascular magnetic resonance in relation to left ventricular function, myocardial scarring and QRS duration in patients with heart failure
por: Foley, Paul WX, et al.
Publicado: (2009)

Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias
por: Okafor, Osita, et al.
Publicado: (2019)

Timing of cardiac resynchronization therapy implantation
por: Leyva, Francisco, et al.
Publicado: (2023)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

Improved prognosis after cardiac resynchronization therapy over a decade
por: Leyva, Francisco, et al.
Publicado: (2023)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Is Cardiac Resynchronisation Therapy Proarrhythmic?
por: Leyva, Francisco, et al.
Publicado: (2008)

Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy
por: Leyva, F, et al.
Publicado: (2009)

Cardiac resynchronization therapy guided by cardiovascular magnetic resonance
por: Leyva, Francisco
Publicado: (2010)

Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function
por: Jones, Siana, et al.
Publicado: (2017)

Incidental cardiac findings on computed tomography imaging of the thorax
por: Foley, Paul WX, et al.
Publicado: (2010)

Successful Catheter Ablation of Ventricular Tachycardia Precipitated by Cardiac Resynchronization Therapy
por: Rauf, Muhammad Atif, et al.
Publicado: (2023)

Long‐Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing
por: Leyva, Francisco, et al.
Publicado: (2018)

Acute Hemodynamic Effects of Simultaneous and Sequential Multi-Point Pacing in Heart Failure Patients With an Expected Higher Rate of Sub-response to Cardiac Resynchronization Therapy: Results of Multicenter SYNSEQ Study
por: Sterliński, Maciej, et al.
Publicado: (2022)

Left ventricular scar and the acute hemodynamic effects of multivein and multipolar pacing in cardiac resynchronization
por: Jackson, Tom, et al.
Publicado: (2018)

Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective
por: Leyva, Francisco, et al.
Publicado: (2021)

Cardiac Resynchronization Therapy Delivered Via a Multipolar Left Ventricular Lead is Associated with Reduced Mortality and Elimination of Phrenic Nerve Stimulation: Long‐Term Follow‐Up from a Multicenter Registry
por: BEHAR, JONATHAN M., et al.
Publicado: (2015)

Does cardiac resynchronization therapy restore peripheral circulatory homeostasis?
por: Ajaero, Chukwudiebube N., et al.
Publicado: (2017)

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
por: Cleland, John G., et al.
Publicado: (2013)

The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta‐analysis of COMPANION and CARE‐HF
por: Cleland, John G.F., et al.
Publicado: (2022)

Long‐term outcomes of cardiac resynchronization therapy in adult congenital heart disease
por: Leyva, Francisco, et al.
Publicado: (2019)

Survival after cardiac resynchronization therapy: results from 50 084 implantations
por: Leyva, Francisco, et al.
Publicado: (2019)

Mortality and Heart Failure After Upgrade to Cardiac Resynchronization Therapy
por: Beca, Bogdan, et al.
Publicado: (2019)

When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it
por: Pabari, Punam A., et al.
Publicado: (2010)

Cost-Effectiveness Analysis of Quadripolar Versus Bipolar Left Ventricular Leads for Cardiac Resynchronization Defibrillator Therapy in a Large, Multicenter UK Registry
por: Behar, Jonathan M., et al.
Publicado: (2017)

Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study
por: Sack, Stefan, et al.
Publicado: (2011)

Sex‐Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Development and Validation of Predictive Models of Cardiac Mortality and Transplantation in Resynchronization Therapy
por: Rocha, Eduardo Arrais, et al.
Publicado: (2015)

Cardiac Resynchronization Therapy in Children
por: Batra, Anjan S, et al.
Publicado: (2009)

Advances in Cardiac Resynchronization Therapy
por: Jafferani, Asif, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy in Pediatrics
por: Hill, Allison C., et al.
Publicado: (2018)

Cardiac Resynchronization Therapy Vegetations
por: Hamada, Abdel Haleem Shawky, et al.
Publicado: (2023)

Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial
por: Whinnett, Zachary I., et al.
Publicado: (2019)

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
por: Leyva, Francisco, et al.
Publicado: (2018)

Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
por: Donnellan, Eoin, et al.
Publicado: (2020)

Judgement of the multidisciplinary team is an important predictor of mortality after cardiac resynchronization therapy
por: Passos, Luiz Carlos Santana, et al.
Publicado: (2021)

Prinicipal component analysis of myocardial strains to optimize cardiac resynchronization therapy patient selection
por: Ramachandran, Raghav, et al.
Publicado: (2014)

Imaging techniques in cardiac resynchronization therapy
por: Sá, Maria Isabel, et al.
Publicado: (2007)

Cardiac Resynchronization Therapy in the Cardiorenal Syndrome
por: Davis, Margot K., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tt2vsmobfba5rc27ngfi6sm1bb